Your Health, We Care
Revumenib is a prescription medicine indicated for the treatment of adult and pediatric patients aged 1 year and older with the following conditions:
1. Acute leukemia with lysine methyltransferase 2A (KMT2A) gene rearrangement, whose disease has relapsed or failed to improve following prior therapy;
2. Acute myeloid leukemia (AML) with nucleophosmin 1 (NPM1) gene mutation, whose disease has relapsed or failed to improve following prior therapy, and who have no other satisfactory treatment options.
FDA，2025.10
Your doctor may prescribe Revuforj tablets in multiple dosage strengths, and it is crucial that you ···【more】
Recommended：112026-28-01
Revumenib is a menin inhibitor that blocks the interaction between wild-type lysine methyltransferas···【more】
Recommended：132026-28-01
Your doctor may prescribe Revuforj tablets in multiple dosage strengths, and it is crucial that you understand how to take the medication correctly. Be sure to know the exact numbe···【more】
Article source：Lucius LaosRelease date：2026-01-28Recommended：11
Revumenib is a menin inhibitor that blocks the interaction between wild-type lysine methyltransferase 2A (KMT2A), KMT2A fusion proteins and menin.What is the indication for Revufor···【more】
Article source：Lucius LaosRelease date：2026-01-28Recommended：13
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
